Nath Bio-Genes (India) Limited Stock Price Today (NSE: NATHBIOGEN)
Nath Bio-Genes (India) Limited
Fundamental Score
Nath Bio-Genes (India) Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Nath Bio-Genes (India) Limited share price today is ₹148.38, down 2.25% on NSE/BSE as of 22 September 2026. Nath Bio-Genes (India) Limited (NATHBIOGEN) is a Small-cap company in the Other Agricultural Products sector with a market capitalisation of ₹281.98 (Cr). The 52-week high for NATHBIOGEN share price is ₹204.00 and the 52-week low is ₹126.15. At a P/E ratio of 8.05x, NATHBIOGEN is currently trading below its industry average P/E of 19.03x. 0
Nath Bio-Genes (India) Limited Share Price Chart — NSE/BSE Historical Performance
Nath Bio-Genes (India) Limited share price chart: -2.66% return over the past month. 52-week high ₹204.00, 52-week low ₹126.15.
Nath Bio-Genes (India) Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹149.00 | ₹152.90 | ₹145.02 | ₹151.80 | 1.10L (Cr) | |
| ₹148.14 | ₹149.00 | ₹146.50 | ₹147.34 | 54.19K (Cr) | |
| ₹147.00 | ₹149.08 | ₹145.00 | ₹148.14 | 2.67K (Cr) | |
| ₹145.00 | ₹147.93 | ₹144.26 | ₹146.05 | 3.31K (Cr) | |
| ₹147.78 | ₹150.00 | ₹146.00 | ₹146.81 | 7.16K (Cr) | |
| ₹150.95 | ₹150.95 | ₹141.30 | ₹147.78 | 29.65K (Cr) | |
| ₹153.00 | ₹153.45 | ₹151.01 | ₹152.51 | 2.25K (Cr) | |
| ₹152.01 | ₹153.48 | ₹149.11 | ₹151.67 | 9.45K (Cr) | |
| ₹152.27 | ₹153.95 | ₹149.98 | ₹152.01 | 17.41K (Cr) | |
| ₹152.20 | ₹154.00 | ₹150.29 | ₹152.65 | 5.11K (Cr) |
Nath Bio-Genes (India) Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹158.30 | ₹158.30 | ₹141.30 | ₹151.80 | -4.11% | |
| ₹160.00 | ₹167.25 | ₹151.15 | ₹158.20 | -1.13% | |
| ₹163.20 | ₹170.00 | ₹153.61 | ₹159.18 | -2.46% | |
| ₹176.08 | ₹180.69 | ₹157.62 | ₹164.77 | -6.42% | |
| ₹196.01 | ₹197.62 | ₹153.63 | ₹175.18 | -10.63% | |
| ₹135.00 | ₹204.00 | ₹133.20 | ₹196.01 | +45.19% | |
| ₹142.01 | ₹150.01 | ₹126.15 | ₹129.02 | -9.15% | |
| ₹147.99 | ₹157.89 | ₹145.25 | ₹150.07 | +1.41% | |
| ₹155.48 | ₹164.99 | ₹136.00 | ₹147.86 | -4.90% | |
| ₹159.75 | ₹163.13 | ₹139.98 | ₹155.49 | -2.67% | |
| ₹175.00 | ₹176.90 | ₹148.01 | ₹156.40 | -10.63% | |
| ₹164.91 | ₹181.90 | ₹161.55 | ₹173.68 | +5.32% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Nath Bio-Genes (India) Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Nath Bio-Genes (India) Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of NATHBIOGEN across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Attractive Valuation (P/E: 8.05 vs Industry: 19.03)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Strong Revenue Growth (15.76%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Conservative Debt Levels (D/E: 0.20)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Healthy Liquidity Position (Current Ratio: 1.97)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Strong Cash Generation (₹93.65 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Risk Factors
5 factors identified
Below-Average Return on Equity (0.00%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (9.14%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Profit Decline Concern (-101.06%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Weak Earnings Growth (-6.46% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Limited Institutional Interest (FII+DII: 0.23%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
Nath Bio-Genes (India) Limited vs Other Agricultural Products Peers
Peer Comparison - Other Agricultural Products
Compare Nath Bio-Genes (India) Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Nath Bio-Genes (India) LimitedNath Bio-Genes ...Selected✓ NATHBIOGEN • 537291 | 15.3/100 | ₹148.38₹148 | ₹281.98₹281.98 | 8.05Average 8.1 Average | 0.00%Poor 0.00% Poor | 9.14%Poor 9.14% Poor | 0.20Excellent 0.2 Excellent | — — | 7.67%Good 7.67% Good | 1.25% |
LT Foods LimitedLT Foods Limite... LTFOODS • 532783 | 59.6/100 | ₹450.30₹450 | ₹15636.80₹15636.80 | 24.42Average 24.4 Average | 0.00%Poor 0.00% Poor | 20.11%Excellent 20.11% Excellent | 0.22Excellent 0.2 Excellent | 17.99%Excellent 17.99% Excellent | 18.70%Excellent 18.70% Excellent | 0.78% |
KRBL LimitedKRBL Limited... KRBL • 530813 | 45.2/100 | ₹433.50₹434 | ₹9922.82₹9922.82 | 13.08Average 13.1 Average | 11.73%Average 11.73% Average | 15.54%Good 15.54% Good | 0.03Excellent 0.0 Excellent | 2.95%Average 2.95% Average | 8.84%Good 8.84% Good | 0.97% |
Gujarat Ambuja Exports LimitedGujarat Ambuja ... GAEL • 524226 | 45.1/100 | ₹165.47₹165 | ₹7590.11₹7590.11 | 18.24Average 18.2 Average | 9.66%Poor 9.66% Poor | 13.10%Average 13.10% Average | 0.13Excellent 0.1 Excellent | -2.08%Poor -2.08% Poor | 4.01%Average 4.01% Average | 0.17% |
Kaveri Seed Company LimitedKaveri Seed Com... KSCL • 532899 | 51.8/100 | ₹723.70₹724 | ₹3722.64₹3722.64 | 15.07Average 15.1 Average | 18.17%Good 18.17% Good | 18.21%Good 18.21% Good | 0.00Excellent 0.0 Excellent | -0.96%Poor -0.96% Poor | 6.12%Good 6.12% Good | 0.59% |
Sanstar LimitedSanstar Limited... SANSTAR • 544217 | 39.7/100 | ₹110.18₹110 | ₹2206.35₹2206.35 | 45.91Average 45.9 Average | 5.09%Poor 5.09% Poor | 5.51%Poor 5.51% Poor | 0.03Excellent 0.0 Excellent | 19.99%Excellent 19.99% Excellent | 19.85%Excellent 19.85% Excellent | 0.00% |
GRM Overseas LimitedGRM Overseas Li... GRMOVER • 531449 | 40.4/100 | ₹85.57₹86 | ₹1773.10₹1773.10 | 13.54Average 13.5 Average | 14.47%Average 14.47% Average | 23.69%Excellent 23.69% Excellent | 0.61Good 0.6 Good | 10.46%Good 10.46% Good | 18.11%Excellent 18.11% Excellent | 0.00% |
Chaman Lal Setia Exports LimitedChaman Lal Seti... CLSEL • 530307 | 54.6/100 | ₹307.50₹308 | ₹1529.07₹1529.07 | 12.21Average 12.2 Average | 14.61%Average 14.61% Average | 19.04%Good 19.04% Good | 0.10Excellent 0.1 Excellent | 6.96%Good 6.96% Good | 11.07%Good 11.07% Good | 0.89% |
AVT Natural Products LimitedAVT Natural Pro... AVTNPL • 519105 | 58.2/100 | ₹91.25₹91 | ₹1389.59₹1389.59 | 16.59Average 16.6 Average | 0.00%Poor 0.00% Poor | 16.93%Good 16.93% Good | 0.20Excellent 0.2 Excellent | 7.57%Good 7.57% Good | 8.01%Good 8.01% Good | 1.13% |
Gulshan Polyols LimitedGulshan Polyols... GULPOLY • 532457 | 58.1/100 | ₹180.49₹180 | ₹1125.73₹1125.73 | 7.62Average 7.6 Average | 16.09%Good 16.09% Good | 21.93%Excellent 21.93% Excellent | 0.43Excellent 0.4 Excellent | 11.40%Good 11.40% Good | 24.73%Excellent 24.73% Excellent | 0.17% |
53.4/100 | ₹90.24₹90 | ₹946.95₹946.95 | 32.70Average 32.7 Average | 22.68%Excellent 22.68% Excellent | 29.10%Excellent 29.10% Excellent | 0.83Good 0.8 Good | 35.75%Excellent 35.75% Excellent | 14.96%Good 14.96% Good | 0.00% | |
Top Other Agricultural Products Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- LT Foods Limited share price15636.80 Cr
- KRBL Limited share price9922.82 Cr
- Gujarat Ambuja Exports Limited share price7590.11 Cr
- Kaveri Seed Company Limited share price3722.64 Cr
- Sanstar Limited share price2206.35 Cr
Nath Bio-Genes (India) Limited PE Ratio History
Historical price-to-earnings ratio for NATHBIOGEN — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹20.14 | ₹155.49 | 7.7x |
| FY 2024 | ₹21.34 | ₹186.56 | 8.7x |
| FY 2023 | ₹18.43 | ₹207.40 | 11.3x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Nath Bio-Genes (India) Limited Dividend History
Annual cash dividends paid by NATHBIOGEN — dividend yield 1.25%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹3.80 Cr |
| FY 2024 | ₹3.80 Cr |
| FY 2023 | ₹3.80 Cr |
| FY 2022 | ₹3.80 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Nath Bio-Genes (India) Limited Quarterly Performance
Latest quarterly metrics for NATHBIOGEN — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
15.76%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-101.06%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
7.67%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Nath Bio-Genes (India) Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for NATHBIOGEN — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Nath Bio-Genes (India) Limited Financial Statements
Annual income statement, balance sheet and cash flow for Nath Bio-Genes (India) Limited (NATHBIOGEN) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Nath Bio-Genes (India) Limited
About NATHBIOGEN (Nath Bio-Genes (India) Limited)
Nath Bio-Genes India Limited is a pioneering force in the realm of Indian agricultural innovation, focusing on developing and distributing cutting-edge solutions for enhancing crop... yields and promoting sustainable farming practices. The company is dedicated to researching, producing, and marketing a diverse portfolio of high-quality agricultural products beyond conventional seeds. These include bio-stimulants, soil conditioners, and crop protection agents, all designed to work synergistically with traditional farming methods to improve plant health and resilience. NATHBIOGEN aims to empower farmers with the tools and knowledge they need to maximize productivity while minimizing their environmental footprint, fostering a future where agriculture is both efficient and environmentally responsible. Beyond seeds, NATHBIOGEN is invested in the development of advanced agricultural technologies aimed at optimizing resource utilization and reducing crop losses. This includes precision farming solutions like drone-based crop monitoring and data-driven irrigation management systems. By leveraging the power of technology, NATHBIOGEN seeks to provide farmers with real-time insights into crop health, enabling them to make informed decisions about planting, fertilization, and pest control. This proactive approach to agriculture not only boosts crop yields but also minimizes the use of water, fertilizers, and pesticides, contributing to a more sustainable and environmentally friendly farming ecosystem. The company understands agriculture's ever-evolving landscape, and is actively exploring sustainable and regenerative agriculture practices to protect farmland. At the heart of NATHBIOGEN's operations is a deep commitment to farmer education and support. The company recognizes that simply providing innovative products is not enough; farmers need to understand how to effectively use these tools to achieve optimal results. To this end, NATHBIOGEN invests heavily in training programs, field demonstrations, and advisory services, ensuring that farmers have access to the knowledge and expertise they need to succeed. By building strong relationships with farmers and providing ongoing support, NATHBIOGEN aims to create a collaborative ecosystem where innovation and practical knowledge converge to drive sustainable agricultural growth and improve the livelihoods of farming communities across India and beyond.
Company Details
Key Leadership
NATHBIOGEN Share Price: Frequently Asked Questions
What is the current share price of Nath Bio-Genes (India) Limited?
Nath Bio-Genes (India) Limited (NATHBIOGEN) trades at ₹148.38 on NSE and BSE. Market cap ₹281.98 (Cr). Educational data only.
What is the P/E ratio of Nath Bio-Genes (India) Limited?
Nath Bio-Genes (India) Limited has a P/E of 8.05x vs industry average 19.03x.
What is the Bull Run score for Nath Bio-Genes (India) Limited?
Nath Bio-Genes (India) Limited has a Bull Run score of 15.3/100 based on 25+ financial parameters.
Does Nath Bio-Genes (India) Limited pay dividends?
Nath Bio-Genes (India) Limited has a dividend yield of 1.25%. Past dividends don't guarantee future payments.
What is the ROE of Nath Bio-Genes (India) Limited?
Nath Bio-Genes (India) Limited has ROE of 0.00%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Nath Bio-Genes (India) Limited?
Nath Bio-Genes (India) Limited has debt-to-equity of 0.20.
Is Nath Bio-Genes (India) Limited a good investment?
Bull Run gives Nath Bio-Genes (India) Limited a score of 15.3/100. This is not investment advice — consult a SEBI-registered advisor.